Form 4: Guardant Health CIO Kalia Vests Equity

Guardant Health's Chief Information Officer, Kumud Kalia, reported the vesting of performance-based and standard restricted stock units, alongside a tax-related share disposition.

Summary

• Kumud Kalia, Chief Information Officer of Guardant Health, Inc. (GH), reported transactions on March 15, 2026.
• Kalia acquired 12,856 shares of Common Stock upon the vesting of performance-based restricted stock units (RSUs) granted on June 7, 2023, after achieving the second tranche performance metric.
• Kalia also acquired 637 shares of Common Stock from the vesting of a restricted stock unit award granted on June 9, 2023.
• Concurrently, 6,839 shares of Common Stock were disposed of at a price of $85.49 per share to cover tax withholding obligations related to the RSU vesting.
• Following these transactions, Kalia directly beneficially owns 44,297 shares of Common Stock.
• Kalia holds 638 unvested Restricted Stock Units.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive event, reflecting the routine vesting of executive compensation and the achievement of performance metrics, which aligns executive interests with shareholder value.

Positives

• Achievement of performance metrics for 12,856 performance-based restricted stock units indicates successful execution against company goals.
• The vesting of restricted stock units demonstrates continued employee retention and alignment of management interests with shareholders.

Negatives

• The disposition of 6,839 shares to cover tax obligations represents a reduction in direct share ownership, though it is a standard practice for RSU vesting.

Future Outlook

The filing indicates that 67% of the restricted stock units granted on June 9, 2023, will vest in equal quarterly installments over the remaining two-year period after June 15, 2024.

Industry Context

StockSavvy.ai notes that routine insider equity vesting and tax-related dispositions are common across the biotechnology and healthcare technology sectors, reflecting standard executive compensation practices tied to long-term incentives.

Comparison to Industry Standards

• StockSavvy.ai observes that the vesting of performance-based restricted stock units, contingent on achieving specific metrics, aligns with best practices in executive compensation across the S&P 500, such as those seen at companies like Illumina or Exact Sciences, which often tie a significant portion of executive pay to performance-based equity to incentivize long-term value creation.
• The tax withholding mechanism is also a standard industry practice.

Related Party Transactions

• The vesting of restricted stock units and subsequent disposition of shares for tax withholding by a Chief Information Officer is a routine related-party transaction as part of executive compensation.

Stakeholder Impact

• Shareholders: The vesting and subsequent tax-related sale of shares by a key executive is a routine event and generally has minimal direct impact on share price, but it signifies the executive's continued equity stake and alignment with company performance.
• Employees: The vesting of performance-based awards can serve as a positive signal regarding the company's achievement of internal goals and its commitment to executive compensation plans.

Next Steps

• Remaining 67% of restricted stock units granted on June 9, 2023, will vest in equal quarterly installments over the remaining two-year period after June 15, 2024.

Key Dates

Recommendation

This Form 4 filing details routine insider transactions related to executive compensation (RSU vesting and tax withholding). It does not provide new material information about the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. The transactions are expected and do not indicate a significant shift in insider sentiment or company prospects.

Keywords

Guardant Health, GH, Kumud Kalia, Chief Information Officer, Form 4, SEC Filing, Insider Transaction, Restricted Stock Units, RSU Vesting, Equity Compensation, Stock Ownership